Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
Sélectionnez vos espèces d'intérêt
Expression of cells a mutant CDK4 (CDK4(R24C)) in beta-cells enhanced beta-cell replication. CDK4(R24C) also dampened compensatory beta-cell neogenesis in larvae and improved glucose tolerance in adult zebrafish.
Inhibition of CDK4/6 is potentially a highly effective strategy for the treatment of SHH (Montrer SHH Protéines) and MYC (Montrer MYC Protéines)-amplified group 3 medulloblastoma.
SOX12 (Montrer SOX12 Protéines) can increase the expression of CDK4 and IGF2BP1 (Montrer IGF2BP1 Protéines), which confer malignant phenotypes to Hepatocellular Carcinoma.
Study showed that CDK4 and BCAS2 (Montrer BCAS2 Protéines) may be target genes of miR (Montrer MLXIP Protéines)-486 and levels of CDK4 and BCAS2 (Montrer BCAS2 Protéines) were both significantly higher in the esophageal cancer tissues and cell lines than levels in the normal tissues and cells.
Results suggest that dysregulation and activation of the cell cycle proteins CDK4/CDK6 (Montrer CDK6 Protéines)-CCND1 (Montrer CCND1 Protéines)-phospho-RB1 (Montrer RB1 Protéines) axis is associated with higher proliferative index in neuroendocrine tumors (NETs).
blocking CDK4 activity efficiently eliminated both normal and chemotherapy-resistant cancer cells in triple negative breast cancers, highlighting CDK4 as a promising novel therapeutic target for these aggressive breast tumors.
Amplification of gene CDK4 is associated with lung adenocarcinoma.
PD-L1 (Montrer CD274 Protéines) protein abundance is regulated by cyclin D-CDK4 and the cullin 3 (Montrer CUL3 Protéines)-SPOP (Montrer SPOP Protéines) E3 ligase via proteasome-mediated degradation
Ongoing trials of doublet and triplet targeted therapies containing ribociclib seek to identify optimal CDK4/6-based targeted combination regimens for various tumor types and advance the field of precision therapeutics in oncology
Transfection of cells with ClC-3 (Montrer CLCN3 Protéines) siRNA decreased the expression of cyclin D1 (Montrer CCND1 Protéines), cyclin dependent kinase 4 and 6, and increased the expression of cyclin dependent kinase (Montrer CDK1 Protéines) inhibitors (CDKIs), p21 (Montrer CDKN1A Protéines) and p27 (Montrer PAK2 Protéines). Pretreatments of cells with p21 (Montrer CDKN1A Protéines) and p27 (Montrer PAK2 Protéines) siRNAs depleted the inhibitory effects of ClC-3 (Montrer CLCN3 Protéines) siRNA on the expression of CDK4 and CDK6 (Montrer CDK6 Protéines), but not on that of cyclin D1 (Montrer CCND1 Protéines)
Palbociclib induces activation of AMPK (Montrer PRKAA1 Protéines) and inhibits hepatocellular carcinoma in a CDK4/6-independent manner
The in vitro cultivation of cumulus cells was associated with cell proliferation and that Cx43 (Montrer GJA1 Protéines) and Cdk4 gene expression was upregulated after in vitro cultivation, resulting in significantly higher protein levels.
These results indicate that p18 (Montrer CDKN2C Protéines) blocks reprogramming by targeting Cdk4/6-mediated cell cycle regulation.
Activation of cdk4 triggers NAFLD.
This novel mechanism explains how CDK4 promotes anabolism by blocking catabolic processes (FAO) that are activated by AMPK (Montrer PRKAA1 Protéines).
PD 0332991 (PD), an FDA-approved selective inhibitor of cyclin-dependent kinase 4/6 (CDK4/6), prevents radiation-induced lethal intestinal injury in mice. Treating mice with PD or a structurally distinct CDK4/6 inhibitor prior to radiation blocked proliferation and crypt apoptosis and improved crypt regeneration.
The results demonstrate a unique CDK4-mediated mitochondrial communication that allows cells to sense environmental genotoxic stress and boost mitochondrial homeostasis by enhancing phosphorylation and activation of MnSOD (Montrer SOD2 Protéines).
a crucial role of RXRa in suppression of UVB-induced melanomas in the context of driver mutations such as activated CDK4(R24C/R24C) or oncogenic NRAS(Q61K) and altered expression of p53 and PTEN
Our data indicate that Cdk2 (Montrer CDK2 Protéines) and Cdk4 play important overlapping roles in homeostatic and stress hematopoiesis, which need to be considered when using broad-spectrum cyclin-dependent kinase (Montrer CDK1 Protéines) inhibitors for cancer therapy.
CDK4 is a critical downstream target of MEN1-dependent tumor suppression and is required for tumorigenic proliferation in the pituitary and pancreatic islet, whereas CDK2 (Montrer CDK2 Protéines) is dispensable for tumorigenesis in these neuroendocrine cell types.
Cdk4 and Cdk6 (Montrer CDK6 Protéines) cooperate in hematopoietic tumor development and suggest a role for Cdk6 (Montrer CDK6 Protéines) in sequestering INK4 proteins away from Cdk4.
CCND1 mRNA expression is increased by FGF9 in bovine theca cells and granulosa cells.
The results indicate that the precise regulation of neuronal Cdk4 activity is important to limit mitochondrial reactive oxygen species production and prevent neurodegeneration.
CDK4 activity regulates mitobiogenesis by the activation of NRF-1 (Montrer NRF1 Protéines) and consequent induction of Tfam (Montrer TFAM Protéines) and mitochondrial ribossomal transcription.
Delg and cyclin D/Cdk4 have roles in nutritional control of mitochondrial biogenesis in the Drosophila adipose tissue
Cyclin D-cdk4 is not a master regulator of cell multiplication in Drosophila embryos
mRpL12 (Montrer MRPL12 Protéines) is required for CycD/Cdk4-induced cell growth
Our data suggest that the growth-specific function of CycD/Cdk4 is conserved from arthropods to mammals.
The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported.
cell division protein kinase 4
, cyclin dependent kinase 4
, serine/threonine kinase
, Cell division protein kinase 4
, Cyclin-dependent kinase 4/6
, cyclin-dependent kinase 4
, protein kinase-like 53C